Bioptik Technology Incorporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 149.09 million compared to TWD 165.77 million a year ago. Net income was TWD 1.01 million compared to TWD 4.25 million a year ago. Basic earnings per share from continuing operations was TWD 0.02 compared to TWD 0.09 a year ago. Diluted earnings per share from continuing operations was TWD 0.02 compared to TWD 0.09 a year ago.
For the six months, sales was TWD 297.9 million compared to TWD 336.63 million a year ago. Net income was TWD 2.93 million compared to TWD 6.22 million a year ago. Basic earnings per share from continuing operations was TWD 0.06 compared to TWD 0.13 a year ago. Diluted earnings per share from continuing operations was TWD 0.06 compared to TWD 0.13 a year ago.